Written question asked by Ian Roome (Liberal Democrat) on Friday, 25 April 2025, in the House of Commons. It was due for an answer on Wednesday, 30 April 2025 (named day). It was answered by Karin Smyth (Labour) on Wednesday, 30 April 2025 on behalf of the Department of Health and Social Care.
Prescription Drugs: Electronic Signatures
- Question
-
To ask the Secretary of State for Health and Social Care, with reference to the Home Office's letter to the Advisory Council on the Misuse of Drugs, dated 29 September 2023, what his Department's planned timetable is for the use of electronic signatures for Schedule 2 and 3 controlled drugs within (a) secondary care and (b) the health and justice system.
- Answer
-
The Department is unable to confirm a timetable at this stage. Amendments to the Human Medicines Regulations 2012 and Misuse of Drug Regulations 2001 would be required to enable electronic prescribing in named settings, such as secondary care and the health and justice system. Changes to this legislation would require public consultation and agreement with Parliament under the affirmative procedure.
Secondary information
- Type
- Written question
- Reference
- 48245
- Session
- 2024-26
- Subjects
- Administration of justice Health services Prescription drugs Electronic signatures
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2025-09-05 22:12:26 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/48245
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/48245
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/48245